Y-mAbs Therapeutics
YMAB
#8232
Rank
NZ$0.31 B
Marketcap
$6.93
Share price
0.24%
Change (1 day)
-73.08%
Change (1 year)

Earnings for Y-mAbs Therapeutics (YMAB)

Earnings in 2024 (TTM): -NZ$51.67 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings are NZ$87.68 Million. a decrease over its 2023 earnings that were of -NZ$43.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Y-mAbs Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$52.39 Million21.54%
2023 -NZ$43.11 Million-72.92%
2022 -NZ$0.16 Billion77.47%
2021 -NZ$89.7 Million-55.46%
2020 -NZ$0.21 Billion44.49%
2019 -NZ$0.14 Billion92.01%
2018 -NZ$72.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion 357.98%๐Ÿ‡บ๐Ÿ‡ธ USA